Metraipolis › archive › dc_c55d770c38bf

Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy:… — Europe PMC PMID:42054640

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42054640
DOI
10.2196/86737
License (as archived)
solo-consultazione
Archived
2026-10-07T17:35:05.011Z
SHA-256 of the archived text
de899adc1137f4bde12f673b1515c6d4d4a1d72483294ad3699bb9377f261261
Stable URL of this page
https://metraipolis.com/documento/dc_c55d770c38bf

How to cite

Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy:… — Europe PMC PMID:42054640 — Europe PMC (en), https://europepmc.org/article/MED/42054640 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c55d770c38bf (Metraipolis archive dc_c55d770c38bf, sha256 de899adc1137f4bde12f673b1515c6d4d4a1d72483294ad3699bb9377f261261)
BibTeX
@misc{dcc55d770c38bf,
  title = {Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy:… — Europe PMC PMID:42054640},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42054640},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c55d770c38bf; sha256 de899adc1137f4bde12f673b1515c6d4d4a1d72483294ad3699bb9377f261261},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42054640. Agents can read the archived copy with the MCP tool read_document.